Today is Jummah. Happy Jummah, Happy friday!

Get to know the fact, and the fact itself will set you free!

Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?

Informed 7 days ago

We read with great interest the article by Figueroa-Parra et al illustrating whether patients with rheumatic diseases are at higher risk of the coronavirus disease 2019 (covid-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1 In this study, the authors mentioned the potential benefit of antimalarial drugs for patients with rheumatic diseases in the context of covid-19 pandemic. At present, that is the really pivotal question, whether the antimalarial drugs could reduce the risk of SARS-CoV-2 infection in patients with rheumatic diseases.

Source:  © BMJ


Online E-books, Textbooks and related materials.